To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Collagen metabolism markers as a reflection of bone and soft tissue turnover during the menstrual cycle and oral contraceptive use
Department of Clinical Sciences, Division of Family Medicine, Stockholm, Karolinska Institute, Novum, Huddinge, Sweden.
Department of Health and Environment, Division of Obstetrics and Gynaecology, Faculty of Health Sciences, Linköping, Sweden.ORCID iD: 0000-0002-0071-4383
Department of Clinical Sciences, Division of Family Medicine, Stockholm, Karolinska Institute, Novum, Huddinge, Sweden.
Department of Health and Environment, Division of Obstetrics and Gynaecology, Faculty of Health Sciences, Linköping, Sweden.
Show others and affiliations
2000 (English)In: Contraception, ISSN 0010-7824, E-ISSN 1879-0518, Vol. 61, no 4, p. 265-270Article in journal (Refereed) Published
Abstract [en]

Two different groups of women, 23 healthy young adults and 13 women with chronic posterior pelvic pain, were studied before and during use of oral contraceptives (OC). Collagen metabolism markers-here, the amino terminal propeptide of type I procollagen, the carboxy-terminal telopeptide of type I collagen, and the amino-terminal of procollagen type III-as well as hormones and other endocrine factors indicating the balance between androgen expression/anabolism and catabolism of the subjects (testosterone, sex-hormone binding globulin, and insulin-like growth factor I were measured. Type I procollagen, the carboxy-terminal telopeptide of type I collagen, and the amino-terminal of procollagen type III were all significantly decreased during OC use. These findings implicate OC use-induced changes in collagen type I and III turnover. A shift in the anabolic/catabolic balance was also recorded indicating a less anabolic situation during OC use.

Place, publisher, year, edition, pages
Elsevier, 2000. Vol. 61, no 4, p. 265-270
National Category
Gynaecology, Obstetrics and Reproductive Medicine Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-107994DOI: 10.1016/s0010-7824(00)00106-2ISI: 000088239500004PubMedID: 10899482Scopus ID: 2-s2.0-0033935069OAI: oai:DiVA.org:oru-107994DiVA, id: diva2:1793328
Available from: 2023-08-31 Created: 2023-08-31 Last updated: 2025-02-11Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Brynhildsen, Jan

Search in DiVA

By author/editor
Brynhildsen, Jan
In the same journal
Contraception
Gynaecology, Obstetrics and Reproductive MedicineCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 31 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf